Allarity Therapeutics, Inc.
Recent Filings
All 366 filings →| Form | Description | Date |
|---|---|---|
| 8-K | CURRENT REPORT | Mar 9, 2026 |
| 8-K | CURRENT REPORT | Mar 6, 2026 |
| 8-K | CURRENT REPORT | Feb 19, 2026 |
| S-3 | REGISTRATION STATEMENT | Feb 12, 2026 |
| 8-K | CURRENT REPORT | Feb 4, 2026 |
| 424B5 | PROSPECTUS SUPPLEMENT | Jan 29, 2026 |
| 8-K | CURRENT REPORT | Jan 29, 2026 |
| 4 | OWNERSHIP DOCUMENT | Jan 16, 2026 |
| 8-K | CURRENT REPORT | Dec 23, 2025 |
| 8-K | CURRENT REPORT | Dec 8, 2025 |
Insider Transactions
View all →| Insider | Title | Type | Shares | Owns After | Date |
|---|---|---|---|---|---|
| Graff Jeremy R. | CDO | Award / Grant | 144,441 | 262,924 | Jan 22, 2025 |
| Epshinsky Alexander | CFO | Award / Grant | 29,496 | 85,051 | Jan 22, 2025 |
| Jensen Thomas | CEO | Award / Grant | 396,734 | 396,734 | Jan 22, 2025 |
| Graff Jeremy R. | See Remarks | Award / Grant | 118,483 @ $2.11 | 118,483 | Sep 30, 2024 |